References
- S Peter, DG Nayak, P Philip, and NS Bijlani. (2004). Antiplaque and antigingivitis efficacy of toothpastes containing triclosan and fluoride. Int Dent J 54 (5 Suppl 1):299–303.
- MG Brading, and PD Marsh. The oral environment: The challenge for antimicrobials in oral care products. Int Dent J 53 (6 Suppl 1):353–362.
- P Sreenivasan, and A Gaffar. (2002). Antiplaque biocides and bacterial resistance: A review. J Clin Periodontol 29:965–974.
- PD Marsh. (2003). Plaque as a biofilm: Pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis (9 Suppl 1):16–22.
- PD Marsh, and DJ Bradshaw. (1993). Microbiological effects of new agents in dentifrices for plaque control. Int Dent J 43 (4 Suppl 1):399–406.
- DJ Bradshaw, PD Marsh, GK Watson, and D Cummins. (1993). The effects of triclosan and zinc citrate, alone and in combination, on a community of oral bacteria grown in vitro. J Dent Res 72:25–30.
- KA Saunders, J Greenman, and C McKenzie. (2000). Ecological effects of triclosan and triclosan monophosphate on defined mixed cultures of oral species grown in continuous culture. J Antimicrob Chemoth 45:447–452.
- MG Brading, VJ Cromwell, AK Green, S DeBrabander, T Beasley, and PD Marsh. (2004). The role of triclosan in dentifrice formulations, with particular reference to a new 0.3% triclosan calcium carbonate-based system. Int Dent J 54 (5 Suppl 1):291–298.
- A D'Emanuele, and D Attwood. (2005). Dendrimer-drug interactions. Adv Drug Deliv Rev 57:2147–2162.
- CN Moorefield, and GR Newkome. (2003). Unimolecular micelles: Supramolecular use of dendritic constructs to create versatile molecular containers. CR Chim 6:715–724.
- S-G Sampathkumar, and KJ Yarema. (2005). Targeting cancer cells with dendrimers. Chem Biol 12:5–6.
- DA Tomalia, and JMJ Frechet. Dendrimers and other dendritic polymersJMJ, Frechet, and DA Tomalia. John Wiley & Sons, Chichester, (2001).
- J Kopecek, P Kopeckova, T Minko, and ZR Lu. (2000). HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action. Eur J Pharm Biopharm 50:61–81.
- J Hao, and PWS Heng. (2003). Buccal delivery systems. Drug Dev Ind Pharm 29:821–832.
- T Teorell, and E Stenhagen. (1938). Universal buffer over the pH range 2.0 to 12.0. Biochem Z 299:416–419.